Adaptation of Graph Convolutional Neural Networks and Graph Layer-wise Relevance Propagation to the Spektral library with application to gene expression data of Colorectal Cancer patients

Motivation: Colorectal Cancer has the second-highest mortality rate worldwide, which requires advanced diagnostics and individualized therapies to be developed. Information about the interactions between molecular entities provides valuable information to detect the responsible genes driving cancer progression. Graph Convolutional Neural Networks are able to utilize the prior knowledge provided by interaction networks and the Spektral library adds a performance increase in contrast to standard implementations. Furthermore, machine learning technology shows great potential to assist medical professionals through guided clinical decision support. However, the deep learning models are limited in their application in precision medicine due to their lack to explain the factors contributing to a prediction. Adaption of the Graph Layer-Wise Relevance Propagation methodology to graph-based deep learning models allows to attribute the learned outcome to single genes and determine their relevance. The resulting patient-specific subnetworks then can be used to identify potentially targetable genes. Results: We present an implementation of Graph Convolutional Neural Networks using the Spektral library in combination with adapted functions for Graph Layer-Wise Relevance Propagation. Deep learning models were trained on a newly composed large gene expression dataset of Colorectal Cancer patients with different molecular interaction networks as prior knowledge: Protein-protein interactions from the Human Protein Reference Database and STRING, and pathways from the Reactome database. Our implementation performs comparably with the original implementation while reducing the computation time, especially for large networks. Further, the generated subnetworks are similar to those of the initial implementation and reveal possible, and even more distant, biomarkers and drug targets. ### Competing Interest Statement The authors have declared no competing interest.